CytomX Therapeutics, Inc.
CTMX
$3.79
-$0.09-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 137.05M | 143.63M | 158.09M | 79.89M | 100.62M |
| Total Receivables | 2.01M | 1.63M | 1.87M | 1.96M | 3.10M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.86M | 3.96M | 4.67M | 4.79M | 3.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 143.92M | 149.22M | 164.62M | 86.63M | 107.31M |
|
|
|||||
| Total Current Assets | 143.92M | 149.22M | 164.62M | 86.63M | 107.31M |
| Net Property, Plant & Equipment | 4.70M | 6.54M | 7.89M | 9.28M | 10.60M |
| Long-term Investments | 949.00K | 949.00K | 949.00K | 949.00K | 949.00K |
| Goodwill | 949.00K | 949.00K | 949.00K | 949.00K | 949.00K |
| Total Other Intangibles | 438.00K | 474.00K | 510.00K | 547.00K | 583.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.56M | 1.08M | 1.08M | 1.09M | 1.09M |
| Total Assets | 151.57M | 158.25M | 175.06M | 98.50M | 120.53M |
|
|
|||||
| Total Accounts Payable | 1.30M | 646.00K | 227.00K | 276.00K | 1.09M |
| Total Accrued Expenses | 14.17M | 12.32M | 11.34M | 10.55M | 12.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.24M | 5.60M | 5.44M | 5.29M | 5.15M |
| Total Finance Division Other Current Liabilities | 26.90M | 22.47M | 22.21M | 34.08M | 67.20M |
| Total Other Current Liabilities | 26.90M | 22.47M | 22.21M | 34.08M | 67.20M |
| Total Current Liabilities | 46.62M | 41.03M | 39.22M | 50.20M | 85.77M |
|
|
|||||
| Total Current Liabilities | 46.62M | 41.03M | 39.22M | 50.20M | 85.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 1.44M | 2.86M | 4.24M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.94M | 9.84M | 14.48M | 20.39M | 30.98M |
| Total Liabilities | 52.56M | 50.87M | 55.15M | 73.45M | 120.99M |
|
|
|||||
| Common Stock & APIC | 810.85M | 789.72M | 788.09M | 693.10M | 691.10M |
| Retained Earnings | -711.95M | -682.44M | -668.21M | -668.05M | -691.58M |
| Treasury Stock & Other | 111.00K | 104.00K | 33.00K | -1.00K | 27.00K |
| Total Common Equity | 99.01M | 107.39M | 119.91M | 25.05M | -456.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.01M | 107.39M | 119.91M | 25.05M | -456.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.01M | 107.39M | 119.91M | 25.05M | -456.00K |
|
|
|||||